|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
57,080,000 |
Market
Cap: |
172.95(M) |
Last
Volume: |
97,895 |
Avg
Vol: |
97,624 |
52
Week Range: |
$1.32 - $4.2 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 5.4 |
Insider 6 Months : 6.1 |
Insider 3/6 Months : 11.5 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
4,500 |
5,000 |
6,598 |
33,898 |
Total Buy Value |
$14,360 |
$15,253 |
$18,107 |
$61,191 |
Total People Bought |
3 |
4 |
4 |
5 |
Total Buy Transactions |
3 |
4 |
5 |
12 |
Total Shares Sold |
25,000 |
25,000 |
25,000 |
45,000 |
Total Sell Value |
$76,500 |
$76,500 |
$76,500 |
$118,240 |
Total People Sold |
1 |
1 |
1 |
2 |
Total Sell Transactions |
2 |
2 |
2 |
4 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lewis Joel |
Director |
|
2017-12-14 |
4 |
A |
$2.39 |
$55,001 |
D/D |
23,013 |
50,880 |
|
- |
|
Rubin Marc |
Director |
|
2017-12-08 |
4 |
B |
$1.85 |
$12,972 |
D/D |
7,000 |
55,581 |
2.39 |
- |
|
Freeman Kevin D |
Director |
|
2017-12-07 |
4 |
B |
$1.64 |
$657 |
D/D |
400 |
28,043 |
2.31 |
- |
|
Freeman Kevin D |
Director |
|
2017-12-07 |
4 |
B |
$1.63 |
$13,005 |
I/I |
8,000 |
8,000 |
2.1 |
- |
|
10x Capital Management, Llc |
10% Owner |
|
2017-06-30 |
4 |
A |
$2.42 |
$230,396 |
D/D |
95,205 |
3,135,150 |
|
- |
|
Czirr James C |
Director |
|
2017-06-30 |
4 |
A |
$2.42 |
$230,396 |
I/I |
95,205 |
3,135,150 |
|
- |
|
Zucconi Theodore Daniel |
Director |
|
2017-05-23 |
4 |
B |
$2.27 |
$2,270 |
D/D |
1,000 |
1,083 |
2.31 |
- |
|
Uihlein Richard E |
10% Owner |
|
2017-04-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20,000 |
|
- |
|
Uihlein Richard E |
10% Owner |
|
2017-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,509,909 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2017-03-31 |
4 |
A |
$1.98 |
$229,979 |
D/D |
116,151 |
3,039,945 |
|
- |
|
Czirr James C |
Director |
|
2017-03-31 |
4 |
A |
$1.98 |
$229,979 |
I/I |
116,151 |
3,039,945 |
|
- |
|
Czirr James C |
Director |
|
2017-03-31 |
4 |
A |
$6.00 |
$6,000 |
D/D |
1,000 |
888,630 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2017-01-27 |
4 |
OE |
$3.00 |
$167,502 |
D/D |
55,834 |
2,629,519 |
|
- |
|
Czirr James C |
Director |
|
2016-12-31 |
4/A |
A |
$1.01 |
$213,995 |
I/I |
211,876 |
2,923,794 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-12-31 |
4/A |
A |
$1.01 |
$213,995 |
D/D |
211,876 |
2,923,794 |
|
- |
|
Czirr James C |
Director |
|
2016-12-31 |
4 |
A |
$1.01 |
$213,995 |
D/D |
211,876 |
3,452,303 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-12-31 |
4 |
A |
$1.01 |
$213,995 |
D/D |
211,876 |
3,452,303 |
|
- |
|
Zucconi Theodore Daniel |
Director |
|
2016-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83 |
|
- |
|
Czirr James C |
Director |
|
2016-11-10 |
4 |
D |
$0.78 |
$20,872 |
I/I |
(26,759) |
3,169,356 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-11-10 |
4 |
D |
$0.78 |
$20,872 |
D/D |
(26,759) |
3,169,356 |
|
- |
|
Czirr James C |
Director |
|
2016-10-13 |
4 |
D |
$1.13 |
$259,203 |
I/I |
(229,383) |
3,196,115 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-10-13 |
4 |
D |
$0.86 |
$197,269 |
D/D |
(229,383) |
3,196,115 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-09-30 |
4/A |
D |
$1.13 |
$856,418 |
D/D |
(757,892) |
2,711,918 |
|
- |
|
Czirr James C |
Director |
|
2016-09-30 |
4/A |
D |
$1.13 |
$856,418 |
I/I |
(757,892) |
2,711,918 |
|
- |
|
Czirr James C |
Director |
|
2016-09-30 |
4 |
A |
$1.13 |
$1,130 |
D/D |
1,000 |
887,630 |
|
- |
|
517 Records found
|
|
Page 11 of 21 |
|
|